uniQure develops gene therapies that treat rare genetic conditions by helping patients' bodies produce missing proteins or targeting specific DNA mutations. Its primary commercial product treats hemophilia B, while other programs focus on diseases like Huntington's and ALS. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
